In conclusion, alterations in IFN sensing and signaling impact tumor development and response to immunotherapy in a context dependent manner, highlighting the complexity of the relationship between IFN signaling and cancer immunity, reviewed elsewhere (261). The gene discussed is IFNA1; the disease is neoplasm.